scholarly journals Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population

Neoplasma ◽  
2016 ◽  
Vol 63 (01) ◽  
pp. 107-114 ◽  
Author(s):  
M. SVAJDLER ◽  
J. KASPIRKOVA ◽  
R. MEZENCEV ◽  
J. LACO ◽  
T. TORDAY ◽  
...  
2020 ◽  
Vol 147 (2) ◽  
pp. 461-471 ◽  
Author(s):  
Julia Simon ◽  
Lea Schroeder ◽  
Kate Ingarfield ◽  
Stefan Diehl ◽  
Jill Werner ◽  
...  

1998 ◽  
Vol 14 (2) ◽  
pp. 113-120 ◽  
Author(s):  
S. K. Kassim ◽  
S. A. Ibrahim ◽  
S. Eissa ◽  
S. S. A. Zaki ◽  
M. A. El-Begermy ◽  
...  

It is widely accepted that the Epstein-Barr virus is etiologically associated with the development of nasopharyngeal carcinoma. The human papillomavirus is also associated with inverted papilloma. We used the polymerase chain reaction technique to detect both viruses in both types of tumors. Flow cytometry was also used to study the DNA pattern and proliferative behavior of the tumors in relation to the viruses. EBV was detected in 13/20 (65%) of NPC specimens, and in none of IP (n= 10) or control specimens (n= 10). This indicates the contribution of EBV as an etiologic factor in NPC. Five cases of NPC (25%) were positive for HPV 16, two of them were EBV positive. Four HPV 16 positive cases were found among cases with inverted papilloma, but none among the control cases. Flow cytometry revealed that all NPC, IP, and control samples were diploid except one aneuploid NPC sample. Proliferative capacity (PC) of primary tumors was predictive of tumor recurrence in NPC. Using 13.6% as a cut-off point for PC, we were able to discriminate between high risk and low risk groups with 100% sensitivity and 86% specificity. PC can be used as a baseline prognostic parameter in NPC, making it possible to modify courses of treatment in an attempt to inhibit tumor recurrence.


1995 ◽  
Vol 113 (2) ◽  
pp. P76-P76
Author(s):  
Christopher H. Rassekh ◽  
Peter Rady ◽  
Stephen Tyring ◽  
Istvan Arany ◽  
Sharen Knudsen ◽  
...  

Head & Neck ◽  
2013 ◽  
Vol 36 (4) ◽  
pp. 511-516 ◽  
Author(s):  
Snjezana Dogan ◽  
Matthew L. Hedberg ◽  
Robert L. Ferris ◽  
Tanya J. Rath ◽  
Adel M. Assaad ◽  
...  

1998 ◽  
Vol 108 (3) ◽  
pp. 362-367 ◽  
Author(s):  
Christopher H. Rassekh ◽  
Peter L. Rady ◽  
Istvan Arany ◽  
Stephen K. Tyring ◽  
Sharen Knudsen ◽  
...  

Author(s):  
R. Stephens ◽  
K. Traul ◽  
D. Woolf ◽  
P. Gaudreau

A number of antigens have been found associated with persistent EBV infections of lymphoblastoid cells. Identification and localization of these antigens were principally by immunofluorescence (IF) techniques using sera from patients with nasopharyngeal carcinoma (NPC), Burkitt lymphoma (BL), and infectious mononucleosis (IM). Our study was mainly with three of the EBV related antigens, a) virus capsid antigen (VCA), b) membrane antigen (MA), and c) early antigens (EA) using immunoperoxidase (IP) techniques with electron microscopy (EM) to elucidate the sites of reactivity with EBV and EBV infected cells.Prior to labeling with horseradish peroxidase (HRP), sera from NPC, IM, and BL cases were characterized for various reactivities by the indirect IF technique. Modifications of the direct IP procedure described by Shabo and the indirect IP procedure of Leduc were made to enhance penetration of the cells and preservation of antigen reactivity.


Sign in / Sign up

Export Citation Format

Share Document